Related references
Note: Only part of the references are listed.Characterization of100sequentialSARS-CoV-2convalescent plasma donations
Christof Jungbauer et al.
TRANSFUSION (2021)
Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates
Jim Boonyaratanakornkit et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Immune globulin subcutaneous, human 20% solution (Xembify®), a new high concentration immunoglobulin product for subcutaneous administration
William Alonso et al.
BIOLOGICALS (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Qianqian Li et al.
CELL (2020)
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Lihong Liu et al.
NATURE (2020)
Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience
Jae-Hoon Ko et al.
ANTIVIRAL THERAPY (2018)
Anti-A and anti-B titers in donor plasma, plasma pools, and immunoglobulin final products
John McVey et al.
TRANSFUSION (2015)
Pathogenesis and mechanisms of antibody-mediated hemolysis
Willy A. Flegel
TRANSFUSION (2015)
European consensus proposal for immunoglobulin therapies
W. A. Carrock Sewell et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Meta-analysis: Convalescent blood products for Spanish influenza pneumonia: A future H5N1 treatment?
Thomas C. Luke et al.
ANNALS OF INTERNAL MEDICINE (2006)
ABO and Rh(D) phenotype frequencies of different racial/ethnic groups in the United States
G Garratty et al.
TRANSFUSION (2004)
Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients
YOY Soo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Properties of a new intravenous immunoglobulin (IGIV-C, 10%) produced by virus inactivation with caprylate and column chromatography
W Lebing et al.
VOX SANGUINIS (2003)
Share Paper
